These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 28972490

  • 21. In vivo purging with rituximab prior to collection of stem cells for autologous transplantation in chronic lymphocytic leukemia.
    Berkahn L, Simpson D, Raptis A, Klingemann HG.
    J Hematother Stem Cell Res; 2002 Apr; 11(2):315-20. PubMed ID: 11983102
    [Abstract] [Full Text] [Related]

  • 22. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A, Dasić G, Sabioncello A, Rabatić S, Reckzeh B, Havemann K, Kardum I, Jacksić B, Vitale B.
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [Abstract] [Full Text] [Related]

  • 23. Residual cancer lymphocytes in patients with chronic lymphocytic leukemia after therapy show increased expression of surface antigen CD52 detected using quantitative fluorescence cytometry.
    Pevna M, Doubek M, Coupek P, Stehlikova O, Klabusay M.
    Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):411-8. PubMed ID: 25066039
    [Abstract] [Full Text] [Related]

  • 24. MD-1 downregulation is associated with reduced cell surface CD180 expression in CLL.
    Edwards K, Manoussaka M, Sayed U, Tsertsvadze T, Deyn L, Nathwani A, Gribben JG, Krysov S, Volpi EV, Lydyard PM, Porakishvili N.
    Leuk Res; 2024 Aug; 143():107540. PubMed ID: 38897026
    [Abstract] [Full Text] [Related]

  • 25. Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells.
    Fanger NA, Wardwell K, Shen L, Tedder TF, Guyre PM.
    J Immunol; 1996 Jul 15; 157(2):541-8. PubMed ID: 8752900
    [Abstract] [Full Text] [Related]

  • 26. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J, Babusíková O.
    Neoplasma; 2004 Jul 15; 51(2):97-102. PubMed ID: 15190418
    [Abstract] [Full Text] [Related]

  • 27. The role of CD180 in hematological malignancies and inflammatory disorders.
    Edwards K, Lydyard PM, Kulikova N, Tsertsvadze T, Volpi EV, Chiorazzi N, Porakishvili N.
    Mol Med; 2023 Jul 17; 29(1):97. PubMed ID: 37460961
    [Abstract] [Full Text] [Related]

  • 28. Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.
    Polk A, Lu Y, Wang T, Seymour E, Bailey NG, Singer JW, Boonstra PS, Lim MS, Malek S, Wilcox RA.
    Clin Cancer Res; 2016 Dec 15; 22(24):6118-6128. PubMed ID: 27334834
    [Abstract] [Full Text] [Related]

  • 29. Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).
    Uhrmacher S, Schmidt C, Erdfelder F, Poll-Wolbeck SJ, Gehrke I, Hallek M, Kreuzer KA.
    Leuk Res; 2011 Oct 15; 35(10):1360-6. PubMed ID: 21531460
    [Abstract] [Full Text] [Related]

  • 30. Dysregulated Fc receptor function in active rheumatoid arthritis.
    Magnusson SE, Wennerberg E, Matt P, Lindqvist U, Kleinau S.
    Immunol Lett; 2014 Nov 15; 162(1 Pt A):200-6. PubMed ID: 25194756
    [Abstract] [Full Text] [Related]

  • 31. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H.
    Arthritis Rheum; 2004 May 15; 50(5):1457-67. PubMed ID: 15146415
    [Abstract] [Full Text] [Related]

  • 32. Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies.
    Le Garff-Tavernier M, Decocq J, de Romeuf C, Parizot C, Dutertre CA, Chapiro E, Davi F, Debré P, Prost JF, Teillaud JL, Merle-Beral H, Vieillard V.
    Leukemia; 2011 Jan 15; 25(1):101-9. PubMed ID: 20975664
    [Abstract] [Full Text] [Related]

  • 33. Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus.
    Li Y, Lee PY, Sobel ES, Narain S, Satoh M, Segal MS, Reeves WH, Richards HB.
    Arthritis Res Ther; 2009 Jan 15; 11(1):R6. PubMed ID: 19144150
    [Abstract] [Full Text] [Related]

  • 34. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
    Własiuk P, Tomczak W, Zając M, Dmoszyńska A, Giannopoulos K.
    Hum Immunol; 2013 Dec 15; 74(12):1592-7. PubMed ID: 23994589
    [Abstract] [Full Text] [Related]

  • 35. Empirical Study on Exploring the Role of CD180 and MD-1 Prognostic Indicators for the Chronic Lymphocytic Leukaemia (CLL) Disease.
    Alotaibi MA.
    Pak J Biol Sci; 2023 May 15; 26(6):311-320. PubMed ID: 37902045
    [Abstract] [Full Text] [Related]

  • 36. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.
    Tsimberidou AM, Kantarjian HM, Cortes J, Thomas DA, Faderl S, Garcia-Manero G, Verstovsek S, Ferrajoli A, Wierda W, Alvarado Y, O'Brien SM, Albitar M, Keating MJ, Giles FJ.
    Cancer; 2003 Apr 01; 97(7):1711-20. PubMed ID: 12655528
    [Abstract] [Full Text] [Related]

  • 37. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.
    Wolska A, Cebula-Obrzut B, Smolewski P, Robak T.
    Leuk Lymphoma; 2013 Jun 01; 54(6):1268-78. PubMed ID: 23078646
    [Abstract] [Full Text] [Related]

  • 38. Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates.
    Grage-Griebenow E, Flad HD, Ernst M, Bzowska M, Skrzeczyñska J, Pryjma J.
    Immunobiology; 2000 May 01; 202(1):42-50. PubMed ID: 10879688
    [Abstract] [Full Text] [Related]

  • 39. Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19 cells in vivo and in vitro.
    Orsini E, Pasquale A, Maggio R, Calabrese E, Mauro FR, Giammartini E, Guarini A, Foa R.
    Br J Haematol; 2004 Jun 01; 125(6):720-8. PubMed ID: 15180861
    [Abstract] [Full Text] [Related]

  • 40. Immune recovery after fludarabine-cyclophosphamide-rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy.
    Ysebaert L, Gross E, Kühlein E, Blanc A, Corre J, Fournié JJ, Laurent G, Quillet-Mary A.
    Leukemia; 2010 Jul 01; 24(7):1310-6. PubMed ID: 20463751
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.